Skip to main content
See every side of every news story
Published loading...Updated

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests

  • A study led by Lucas Mavromatis at NYU's Grossman School of Medicine found that GLP-1 drugs lowered obesity-related cancer risk in adults with diabetes.
  • Researchers analyzed 170,000 patient records and compared those who took GLP-1 receptor agonists to those who took other diabetes drugs not linked to weight loss.
  • After four years, the GLP-1 group had a 7% lower risk of obesity-related cancers and 2,501 new cancer cases versus 2,671 in the comparison group, with effects seen mainly in women.
  • Dr. Ernest Hawk, not involved in the study, called for more research to confirm these findings, noting this study cannot establish cause and effect but suggests a connection worth exploring.
  • The study, supported by the NIH and shared at the annual meeting of the American Society of Clinical Oncology, suggests that widely used weight-loss medications such as Wegovy and Ozempic may help reduce the risk of certain obesity-related cancers.
Insights by Ground AI

91 Articles

Associated Press NewsAssociated Press News
+78 Reposted by 78 other sources
Lean Left

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 82% of the sources are Center
82% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sci Tech Daily broke the news in on Wednesday, May 21, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal